A groundbreaking blood test measuring tau protein levels could help predict dementia risk up to 25 years before symptoms ...

The Peter & Jeri Dejana Foundation has provided a $5 million gift to Northwell Health’s Feinstein Institutes for Medical ...

A new study indicates that p-tau217 levels in older women can forecast cognitive decline or dementia twenty-five years early.

Don’t sleep on this troubling symptom of Alzheimer’s. Despite primarily affecting people over the age of 65, the most common type of dementia can be detected through early warning signs like poor ...

Researchers said: "Scientists now know that it begins many years before symptoms appear” ...

New research suggests that persistent sleep problems may be more than just a nightly frustration—they could signal early changes in the brain linked to Alzheimer’s disease.

In A Nutshell Women who took a combination of estrogen and progestin showed a stronger link between elevated p-tau 217 and ...

Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...

Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy ...

Manifold Bio, a platform therapeutics company pioneering direct-to-vivo drug discovery, today announced a joint study with NVIDIA to validate Proteina-Complexa, NVIDIA's generative model for protein ...

When jam-packed calendars and seemingly constant takeout orders get you down, diving into a fresh way to rethink homecooked ...